ImmunityBio, Inc. announced that its pivotal randomized BCG-naive non-muscle invasive bladder cancer (NMIBC) trial has demonstrated sufficient statistical power to detect clinically meaningful differences between the Anktiva® plus BCG treatment regimen and BCG alone.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The company also confirmed that the supplemental Biologics License Application (BLA) for the therapy is progressing as planned, with a target completion in 2026.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Silver Price Forecast: False breakout and hawkish Fed sinks XAG
FXStreet•2026/08/28 16:33
Northam CEO says unsolicited M&A approach could spur platinum industry consolidation
Mining.com•2026/08/28 16:33
Update: Market Chatter: Lucid Recalls 27,185 Vehicles Over Lighting Defect
MT newswire•2026/08/28 16:33
Market Chatter: Microsoft Workers Raise Concerns Over AI Data Center Impact
MT newswire•2026/08/28 16:33
Crypto prices
More
Bitcoin
BTC
$77,720.46
-3.30%
Ethereum
ETH
$2,433.24
-3.48%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$689.44
-3.28%
XRP
XRP
$1.39
-5.40%
USDC
USDC
$1
+0.01%
Solana
SOL
$104.53
-3.17%
TRON
TRX
$0.3391
+0.35%
Hyperliquid
HYPE
$81.51
-3.86%
Zcash
ZEC
$792.68
-2.48%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now